Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP
Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle
Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
Prucalopride is prescribed for chronic idiopathic constipation
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
This is the group’s first NoC approval in Canada
Vasograin Plus represents a major advancement in the treatment of migraine
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Subscribe To Our Newsletter & Stay Updated